A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.
about
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastasesChemotherapy for brain metastases from small cell lung cancerBone and brain metastasis in lung cancer: recent advances in therapeutic strategiesEfficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer.Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.Central nervous system cancersWhole brain radiotherapy for brain metastasis.Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis.Investigation of intravenous delivery of nanoliposomal topotecan for activity against orthotopic glioblastoma xenograftsPei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive casesThe biology of brain metastases-translation to new therapiesEvaluation on efficacy and safety of tyrosine kinase inhibitors plus radiotherapy in NSCLC patients with brain metastases.Lung cancer: Biology and treatment options.Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability.Management of brain metastasis: past lessons, modern management, and future considerations.The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review.Brain metastases in non-small-cell lung cancer: better outcomes through current therapies and utilization of molecularly targeted approaches.Systemic therapies in the treatment of non-small-cell lung cancer brain metastases.Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer.Updates in the management of brain metastases.RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt.State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.Effect of chemotherapy on survival after whole brain radiation therapy for brain metastases: a single-center retrospective analysis.[China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].State-of-the-art considerations in small cell lung cancer brain metastases.Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer.A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases.Treatment of Brain Metastases.Therapie von Hirnmetastasen und Meningeosis neoplastica
P2860
Q24200466-9068E8CB-7372-433D-B87D-505814F7E69AQ24202771-4D48EEBE-ED46-4AB7-8F41-1A84A626970EQ24568071-DB81C535-B2BB-42C2-90B2-760F8B433E75Q33599135-BCA4E35D-AA36-4332-A80F-A00B9C94C404Q33777436-145A0EC3-7A4B-46AA-AA70-74A2E9C92AFCQ34014740-BBBFDD15-091A-42A4-922A-3F73EBD534F2Q34347439-B3A9ECE5-C8CF-4DB6-9BE9-C66CBE0F2386Q34408494-ECED4654-C85C-4DC5-A2CC-0F84DBEC0552Q35570265-3EA99227-39DA-44C1-91F8-102C0EE579B8Q35595219-21A61167-43A3-408B-87D5-7A33A1BA8ACCQ35676602-F98B771F-F3E0-4648-87D3-53149E14050EQ36140948-5B59E58C-13B9-440E-821C-E72F624CF377Q36328370-D13CAE56-4D6E-4771-8F6E-42958D6B8B12Q37256355-60923177-4F9A-4938-8CE4-D21B71008AC9Q37724215-1B0B1644-8E3A-4DB2-B77D-3981237E0632Q37954518-17888333-3811-4F4D-AE29-0ECCE701FCD2Q37958051-C4BC7BA2-E473-4B12-94DB-1ADF98F9528BQ38233149-E495784D-CCAA-462C-B05C-6815E8CD7B9CQ38738053-BD9A7406-3B23-4E15-B3EA-16F9E2ECA915Q38763111-F7CC3306-D7F6-4BE2-8632-B8B249D41122Q38809939-CF7DE0B6-6F9B-445C-8DA4-417584D3ACB0Q38887451-5B67F4E0-834A-4E2C-86B8-179C82A79EFAQ38973621-5AFAD97C-8398-4951-89D8-D0AA90A863C4Q38985340-A4C437D8-E827-4E5A-8EC0-1789F0B02278Q39637384-163903C5-09D3-40A6-9FBB-24F6B59FEFFAQ40372968-A33FF239-5F41-4B41-9551-835C6B3DA6D8Q42378525-5F25BADD-9AE0-419C-94F6-63E52987984BQ44722770-E84B9133-5EDE-483A-9AC6-61C748648410Q48167222-8AD443BD-F2DC-46FC-9652-7A7ACAF5CEBCQ53827061-56A3969F-E345-469E-9A92-79C8E919AE21Q58023833-3F15B9E8-EC32-401F-A295-F99ECC7030E1
P2860
A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase III trial of topotecan ...... metastases due to lung cancer.
@en
A phase III trial of topotecan ...... metastases due to lung cancer.
@nl
type
label
A phase III trial of topotecan ...... metastases due to lung cancer.
@en
A phase III trial of topotecan ...... metastases due to lung cancer.
@nl
prefLabel
A phase III trial of topotecan ...... metastases due to lung cancer.
@en
A phase III trial of topotecan ...... metastases due to lung cancer.
@nl
P2093
P2860
P356
P1476
A phase III trial of topotecan ...... metastases due to lung cancer.
@en
P2093
G G Grabenbauer
H Schueller
R P Muller
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604835
P407
P577
2009-01-06T00:00:00Z
P5875
P6179
1039891555